Alembic Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 6/6
Alembic Pharmaceuticals has a total shareholder equity of ₹44.7B and total debt of ₹8.7B, which brings its debt-to-equity ratio to 19.4%. Its total assets and total liabilities are ₹64.6B and ₹19.9B respectively. Alembic Pharmaceuticals's EBIT is ₹6.1B making its interest coverage ratio 10.3. It has cash and short-term investments of ₹1.5B.
Key information
19.4%
Debt to equity ratio
₹8.69b
Debt
Interest coverage ratio | 10.3x |
Cash | ₹1.48b |
Equity | ₹44.70b |
Total liabilities | ₹19.85b |
Total assets | ₹64.55b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 533573's short term assets (₹31.3B) exceed its short term liabilities (₹18.1B).
Long Term Liabilities: 533573's short term assets (₹31.3B) exceed its long term liabilities (₹1.8B).
Debt to Equity History and Analysis
Debt Level: 533573's net debt to equity ratio (16.1%) is considered satisfactory.
Reducing Debt: 533573's debt to equity ratio has reduced from 44.7% to 19.4% over the past 5 years.
Debt Coverage: 533573's debt is well covered by operating cash flow (69.4%).
Interest Coverage: 533573's interest payments on its debt are well covered by EBIT (10.3x coverage).